Novogene Co

Novogene Co Payout Ratio

The Dividend Payout Ratio of Novogene Co (688315.SS) as of Nov 5, 2026 is 11.59 %. In the previous year, Dividend Payout Ratio was 10.08 % — a change of 14.96% (higher).

Payout Ratio

11.59 %

YoY

14.96%

Last updated:

Dividend Payout Ratio of Novogene Co is 2025 11.59 % . Dividend Payout Ratio of Novogene Co was 2024 10.08 % . It decreases by 14.96% higher compared to the previous year.

The payout ratio is around 12% of earnings.

The Novogene Co Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2021
10.80 CNY
Jan 1, 2022
13.62 CNY
Jan 1, 2023
10.73 CNY
Jan 1, 2024
10.08 CNY
Jan 1, 2025
11.59 CNY
Jan 1, 2026 (e)
8.65 CNY
Jan 1, 2027 (e)
7.63 CNY
Jan 1, 2028 (e)
6.72 CNY
The Novogene Co Payout Ratio history
YEARPayout RatioYoY
est6.72 %-11.94%
est7.63 %-11.86%
est8.65 %-25.32%
11.59 %+14.96%
10.08 %-6.04%
10.73 %-21.22%
13.62 %+26.10%
10.80 %0.00%
10.80 %0.00%
10.80 %0.00%
10.80 %0.00%
10.80 %0.00%
10.80 %0.00%
10.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novogene Co Stock analysis

What does Novogene Co do? Novogene Co., Ltd. generates revenue through genomic services and solutions, primarily utilizing high-throughput sequencing and bioinformatics analysis technologies. The company offers life science basic research services, medical research and technical services, and database-building sequencing platform services, targeting both domestic and international markets. Key products include gene mutation detection kits, coronavirus disease nucleic acid test services, and DA8600 sequencers, which are sold to research institutions, medical facilities, and clinical applications. The firm's technology-driven approach enables it to provide multi-level scientific and research technical services across life science and medical fields. Novogene's revenue streams are anchored in its sequencing platforms and equipment, with the DA8600 sequencers representing a significant product line. The company develops and sells genetic testing medical equipment, leveraging its expertise in gene sequencing. Its services are tailored for life science basic research, medical and clinical applications, and database construction, serving a diverse clientele including research organizations and healthcare providers. The firm's focus on multi-omics research technology enhances its ability to deliver comprehensive solutions. The business model integrates high-throughput sequencing technology with bioinformatics analysis to create scalable services. Novogene's offerings span from basic research support to clinical diagnostic tools, with gene mutation detection kits and coronavirus disease nucleic acid test services catering to specific market needs. The company's domestic and overseas market presence ensures broad client reach, while its independent development of sequencing equipment like the DA8600 sequencers drives product-based revenue. This dual focus on services and equipment positions Novogene as a key player in genomic technology solutions. Novogene Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novogene Co stock

Dividend Payout Ratio of Novogene Co is 11.59 % in 2025.

Dividend Payout Ratio of Novogene Co changed from 10.08 % to 11.59 %, representing a 14.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Novogene Co since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Novogene Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Novogene Co

All Key Metrics — Novogene Co